2,4-pentanedione

2,4-pentanedione is a lipid of Fatty Acyls (FA) class. The related lipids are Butyrates.

Cross Reference

Introduction

To understand associated biological information of 2,4-pentanedione, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,4-pentanedione?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,4-pentanedione

MeSH term MeSH ID Detail
Carcinoma, Lewis Lung D018827 22 associated lipids
Per page 10 20 | Total 11

PubChem Associated disorders and diseases

What pathways are associated with 2,4-pentanedione

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,4-pentanedione?

There are no associated biomedical information in the current reference collection.

What functions are associated with 2,4-pentanedione?

There are no associated biomedical information in the current reference collection.

What lipids are associated with 2,4-pentanedione?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 2,4-pentanedione?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,4-pentanedione?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,4-pentanedione

Download all related citations
Per page 10 20 50 100 | Total 1027
Authors Title Published Journal PubMed Link
Venter GJ et al. 4-(2,6-Dibromo-4-fluoro-anilino)pent-3-en-2-one. 2011 Acta Crystallogr Sect E Struct Rep Online pmid:22220097
Mohamed SK et al. N-(4,6-Dimethyl-pyrimidin-2-yl)-1,3-benzothia-zol-2-amine. 2011 Acta Crystallogr Sect E Struct Rep Online pmid:22220133
Stanchev S et al. Synthesis and Inhibiting Activity of Some 4-Hydroxycoumarin Derivatives on HIV-1 Protease. 2011 ISRN Pharm pmid:22389842
Hegazy WH and Al-Motawaa IH Lanthanide Complexes of Substituted β-Diketone Hydrazone Derivatives: Synthesis, Characterization, and Biological Activities. 2011 Bioinorg Chem Appl pmid:21799665
Rajkumar V et al. Antioxidant and Anti-Cancer Potentials of Rheum emodi Rhizome Extracts. 2011 Evid Based Complement Alternat Med pmid:21792364
Ahmed K Biological roles and therapeutic potential of hydroxy-carboxylic Acid receptors. 2011 Front Endocrinol (Lausanne) pmid:22654812
Puglisi A et al. Novel carbohydrate-based bifunctional organocatalysts for nucleophilic addition to nitroolefins and imines. 2011 Org. Biomol. Chem. pmid:21431185
Ebner C et al. Determining the enantioselectivity of chiral catalysts by mass spectrometric screening of their racemic forms. 2011 J. Am. Chem. Soc. pmid:21401128
Arion VB et al. Syntheses, electronic structures, and EPR/UV-vis-NIR spectroelectrochemistry of nickel(II), copper(II), and zinc(II) complexes with a tetradentate ligand based on S-methylisothiosemicarbazide. 2011 Inorg Chem pmid:21361344
Edkins RM et al. The synthesis and photophysics of tris-heteroleptic cyclometalated iridium complexes. 2011 Dalton Trans pmid:21735008